Reduced Cardiac Fructose 2,6 Bisphosphate Increases Hypertrophy and Decreases Glycolysis following Aortic Constriction

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Wang, Jianxun ^a   Xu, Jianxiang ^a   Wang, Qianwen ^a   Brainard, Robert E ^a   Watson, Lewis J ^a   Jones, Steven P ^a   Epstein, Paul N ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; 6 PHOSPHOFRUCTO 2 KINASE; ADENOSINE TRIPHOSPHATE; COLLAGEN TYPE 1; CREATINE PHOSPHATE; FRUCTOSE 2,6 BISPHOSPHATASE; FRUCTOSE 2,6 BISPHOSPHATE; MYOSIN HEAVY CHAIN ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; GLYCOLYSIS; HEART CONTRACTION; HEART INJURY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE FIBROSIS; LUNG CONGESTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; TISSUE LEVEL;

ADENOSINE TRIPHOSPHATE; ANIMALS; AORTA; CARDIOMEGALY; CONSTRICTION, PATHOLOGIC; FIBROSIS; FRUCTOSEDIPHOSPHATES; GLYCOLYSIS; MALE; MICE; MICE, TRANSGENIC; MYOCARDIUM; OXIDATIVE STRESS; PHOSPHOCREATINE; PHOSPHOFRUCTOKINASE-2; VENTRICULAR REMODELING;

MUS; MUS MUSCULUS;

EID: 84872132382     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053951     Document Type: Article

References (40)

1. Bishop SP, Altschuld RA, (1970) Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. AmJPhysiol 218: 153-159.
2. Schwartz K, Boheler KR, de la BD, Lompre AM, Mercadier JJ, (1992) Switches in cardiac muscle gene expression as a result of pressure and volume overload. AmJ Physiol 262: R364-R369.
3. Hamby RI, Zoneraich S, Sherman L, (1974) Diabetic cardiomyopathy. JAMA 229: 1749-1754.
4. Liao R, Jain M, Cui L, D'Agostino J, Aiello F, et al. (2002) Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice. Circulation 106: 2125-2131.
5. Domenighetti AA, Danes VR, Curl CL, Favaloro JM, Proietto J, et al. (2010) Targeted GLUT-4 deficiency in the heart induces cardiomyocyte hypertrophy and impaired contractility linked with Ca(2+) and proton flux dysregulation. J Mol Cell Cardiol 48: 663-672.
6. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, et al. (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. ProcNatlAcadSciUSA 97: 12222-12226.
7. Taylor M, Wallhaus TR, Degrado TR, Russell DC, Stanko P, et al. (2001) An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in Patients with Congestive Heart Failure. Journal of nuclear medicine: official publication, Society of Nuclear Medicine 42: 55-62.
8. Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, et al. (1994) Control of glucose utilization in working perfused rat heart. Journal of Biological Chemistry 269: 25502-25514.
9. Newsholme EA, Randle PJ, (1964) Regulation of glucose uptake by muscle. 7. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes, starvation, hypophysectomy and adrenalectomy, on the concentrations of hexose phosphates, nucleotides and inorganic phosphate in perfused rat heart. BiochemJ 93: 641-651.
10. Hue L, Beauloye C, Marsin AS, Bertrand L, Horman S, et al. (2002) Insulin and ischemia stimulate glycolysis by acting on the same targets through different and opposing signaling pathways. JMolCell Cardiol 34: 1091-1097.
11. Nascimben L, Ingwall JS, Lorell BH, Pinz I, Schultz V, et al. (2004) Mechanisms for increased glycolysis in the hypertrophied rat heart. Hypertension 44: 662-667.
12. Donthi RV, Ye G, Wu C, McClain DA, Lange AJ, et al. (2004) Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. Journal of Biological Chemistry 279: 48085-48090.
13. Wu CD, Okar DA, Peng L, Lange AJ, (2002) Decreasing fructose-2,6-bisphosphate leads to diabetic phenotype in normal mice. Diabetes 51: A319-A319.
14. Facundo HT, Brainard RE, Watson LJ, Ngoh GA, Hamid T, et al. (2012) O-GlcNAc signaling is essential for NFAT-mediated transcriptional reprogramming during cardiomyocyte hypertrophy. American journal of physiology Heart and circulatory physiology 302: H2122-2130.
15. Liang Q, Carlson EC, Donthi RV, Kralik PM, Shen X, et al. (2002) Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes 51: 174-181.
16. Liang Q, Donthi RV, Kralik PM, Epstein PN, (2002) Elevated hexokinase increases cardiac glycolysis in transgenic mice. CardiovascRes 53: 423-430.
17. Watson LJ, Facundo HT, Ngoh GA, Ameen M, Brainard RE, et al. (2010) O-linked beta-N-acetylglucosamine transferase is indispensable in the failing heart. Proc Natl Acad Sci U S A 107: 17797-17802.
18. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome biology 3: RESEARCH0034.
19. Wang J, Song Y, Elsherif L, Song Z, Zhou G, et al. (2006) Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 113: 544-554.
20. Lowry OH, Passonneau JV (1993) A flexible system of enzymatic analysis. New York: Academic.
21. Wang Q, Donthi RV, Wang J, Lange AJ, Watson LJ, et al. (2008) Cardiac phosphatase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase increases glycolysis, hypertrophy, and myocyte resistance to hypoxia. Am J Physiol Heart Circ Physiol 294: H2889-2897.
22. Donthi RV, Ye G, Wu C, McClain DA, Lange AJ, et al. (2004) Cardiac expression of kinase-deficient 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase inhibits glycolysis, promotes hypertrophy, impairs myocyte function, and reduces insulin sensitivity. J Biol Chem 279: 48085-48090.
23. Bernofsky C, Swan M, (1973) An improved cycling assay for nicotinamide adenine dinucleotide. Anal Biochem 53: 452-458.
24. Zerez CR, Lee SJ, Tanaka KR, (1987) Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure. Anal Biochem 164: 367-373.
25. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, et al. (1992) 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 86: 1810-1818.
26. Neubauer S, Horn M, Cramer M, Harre K, Newell JB, et al. (1997) Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 96: 2190-2196.
27. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, et al. (2000) Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. CurrBiol %19 10: 1247-1255.
28. Kim M, Shen M, Ngoy S, Karamanlidis G, Liao R, et al. (2012) AMPK isoform expression in the normal and failing hearts. Journal of molecular and cellular cardiology 52: 1066-1073.
29. Zhang P, Hu X, Xu X, Fassett J, Zhu G, et al. (2008) AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice. Hypertension 52: 918-924.
30. Kockskamper J, Zima AV, Blatter LA, (2005) Modulation of sarcoplasmic reticulum Ca2+ release by glycolysis in cat atrial myocytes. J Physiol 564: 697-714.
31. Kagaya Y, Weinberg EO, Ito N, Mochizuki T, Barry WH, et al. (1995) Glycolytic inhibition: effects on diastolic relaxation and intracellular calcium handling in hypertrophied rat ventricular myocytes. JClinInvest 95: 2766-2776.
32. Ussher JR, Jaswal JS, Lopaschuk GD, (2012) Pyridine nucleotide regulation of cardiac intermediary metabolism. Circulation Research 111: 628-641.
33. Aon MA, Cortassa S, O'Rourke B, (2010) Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta 1797: 865-877.
34. Andres A, Satrustegui J, Machado A, (1980) Development of NADPH-producing pathways in rat heart. The Biochemical journal 186: 799-803.
35. Gupte SA, Levine RJ, Gupte RS, Young ME, Lionetti V, et al. (2006) Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. Journal of molecular and cellular cardiology 41: 340-349.
36. Yamagishi SI, Edelstein D, Du XL, Kaneda Y, Guzman M, et al. (2001) Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. The Journal of biological chemistry. 276: 25096-25100.
37. Lu Z, Xu X, Hu X, Lee S, Traverse JH, et al. (2010) Oxidative stress regulates left ventricular PDE5 expression in the failing heart. Circulation 121: 1474-1483.
38. Takimoto E, Kass DA, (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49: 241-248.
39. Tanaka K, Honda M, Takabatake T, (2001) Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. J Am Coll Cardiol 37: 676-685.
40. Ritchie RH, Quinn JM, Cao AH, Drummond GR, Kaye DM, et al. (2007) The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo. J Mol Cell Cardiol 42: 1119-1128.